entertainment -WSS

entertainment

author：Wikipedia 2025-09-28 00:52:48 - browse：826

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： CDC recommends RSV monoclonal antibody for infants

focus

hotspot

WSS

Can U.S. cancer drug shortages be fixed?

It costs an awful lot of money to give away a kidney

Group behind ProMed defends move to subscription

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Roche's accidental data boosts hopes for anti

Vivek Ramaswamy made waves in the debate, much as in biotech

entertainment

entertainment

focus

How to save PrEP access — and even expand it

The cancer stories no one wants to hear

Medical records are filled with copy

How to make over

In age of alternative facts, a scholarly course on calling out crap

The cancer stories no one wants to hear

Walensky prepares to leave CDC — and Congress — behind

How to make over

Dobbs anniversary: the lost opportunity of abortion as health care

CDC says it’s too soon to assess risk posed by Covid subvariant

focus

Meadows told special counsel he could not recall Trump ever declassifying Mar

Meadows told special counsel he could not recall Trump ever declassifying Mar

Former Pear Therapeutics executives start new VC firm

Listen: Vivek Ramaswamy's star turn & leaky drug data

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

As obesity drug market grows, telehealth companies court payers

knowledge

Wikipedia

hotspot

hotspot